PRN Medication Events in a Forensic Psychiatric Hospital: A Document Analysis of the Prevalence and Reasons

References

• Aho-Mustonen, K., Tiihonen, J., Repo-Tiihonen, E., Ryynänen, O. P., Miettinen, R., & Räty, H. (2011). Group psychoeducation for long-term offender patients with schizophrenia: An exploratory randomized controlled trial. Criminal Behaviour and Mental Health: CBMH, 21(3), 163–176. https://doi.org/10.1002/cbm.788
   PubMed Web of Science ®Google Scholar
• Askola, R., Nikkonen, M., Putkonen, H., Kylmä, J., & Louheranta, O. (2017). The therapeutic approach to a patient’s criminal offense in a forensic mental health nurse-patient relationship: The nurses’ perspectives. Perspectives in Psychiatric Care, 53(3), 164–174. https://doi.org/10.1111/ppc.12148
   PubMed Web of Science ®Google Scholar
• Baker, J. A., Lovell, K., & Harris, N. (2008a). A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings. Journal of Clinical Nursing, 17(9), 1122–1131. https://doi.org/10.1111/j.1365-2702.2007.02236.x
   PubMed Web of Science ®Google Scholar
• Baker, J. A., Lovell, K., & Harris, N. (2008b). The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: An exploratory study. International Journal of Nursing Studies, 45(10), 1403–1410. https://doi.org/10.1016/j.ijnurstu.2008.01.004
   PubMed Web of Science ®Google Scholar
• Baker, J. A., Lovell, K., Harris, N., & Campbell, M. (2007). Multidisciplinary consensus of best practice for pro re nata (PRN) psychotropic medications within acute mental health settings: A Delphi study. Journal of Psychiatric and Mental Health Nursing, 14(5), 478–484. https://doi.org/10.1111/j.1365-2850.2007.01112.x
   PubMed Web of Science ®Google Scholar
• Barr, L., Wynaden, D., & Heslop, K. (2018). Nurses’ attitudes towards the use of PRN psychotropic medications in acute and forensic mental health settings. International Journal of Mental Health Nursing, 27(1), 168–177. https://doi.org/10.1111/inm.12306
   PubMed Web of Science ®Google Scholar
• Bjørkly, S., Hartvig, P., Heggen, F.-A., Brauer, H., & Moger, T. A. (2009). Development of a brief screen for violence risk (V-RISK-10) in acute and general psychiatry: An introduction with emphasis on findings from a naturalistic test of interrater reliability. European Psychiatry: The Journal of the Association of European Psychiatrists, 24(6), 388–394. https://doi.org/10.1016/j.eurpsy.2009.07.004
   PubMed Web of Science ®Google Scholar
• Bowen, G. A. (2009). Document analysis as a qualitative research method. Qualitative Research Journal, 9(2), 27–40. https://doi.org/10.3316/QRJ0902027
   Google Scholar
• Byrne, P. (2018). Physical health in psychiatric patients. Medicine, 46(12), 725–730. https://doi.org/10.1016/j.mpmed.2018.09.002
   Google Scholar
• Crowe, E., Daly, M., Delaney, L., Carroll, S., & Malone, K. M. (2019). The intra-day dynamics of affect, self-esteem, tiredness, and suicidality in major depression. Psychiatry Research, 279, 98–108. https://doi.org/10.1016/j.psychres.2018.02.032
   PubMed Web of Science ®Google Scholar
• Cuomo, A., Beccarini Crescenzi, B., Goracci, A., Bolognesi, S., Giordano, N., Rossi, R., Facchi, E., Neal, S. M., & Fagiolini, A. (2019). Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety, 18(6), 455–463. https://doi.org/10.1080/14740338.2019.1617847
   PubMed Web of Science ®Google Scholar
• Curtis, J., Baker, J. A., & Reid, A. R. (2007). Exploration of therapeutic interventions that accompany the administration of p.r.n. (‘as required’) psychotropic medication within acute mental health settings: A retrospective study. International Journal of Mental Health Nursing, 16(5), 318–326. https://doi.org/10.1111/j.1447-0349.2007.00487.x
   PubMed Web of Science ®Google Scholar
• Douglas-Hall, P., & Whicher, E. V. (2015). As required’ medication regimens for seriously mentally ill people in hospital. Cochrane Database of Systematic Reviews, 2015(12), CD003441.
   Google Scholar
• Ensio, A., Lammintakanen, J., Härkönen, M., & Kinnunen, J. (2019). Finland. In A. M. Rafferty, R. Busse, B. Zander-Jentsch, W. Sermeus, & L. Bruyneel (Eds.), Strengthening health systems through nursing: Evidence from 14 European countries. European Observatory on Health Systems and Policies. Health Policy Series 52 (pp. 31–41). Copenhagen, Denmark: WHO.
   Google Scholar
• Essali, A., Turkmani, K., Aboudamaah, S., AbouDamaah, A., Diaa Aldeen, M. R., Marwa, M. E., & AlMounayer, N. (2019). Haloperidol discontinuation for people with schizophrenia. Cochrane Database of Systematic Reviews, 2019(4), CD011408.
   Google Scholar
• Felthous, A. R., & Saß, H. (2014). Forensic psychiatry. In B. Madea (Ed.), Handbook of forensic medicine (pp. 811–828). Chichester: Wiley and Sons Ltd.
   Google Scholar
• Goedhard, L. E., Stolker, J. J., Nijman, H. L., Egberts, A. C., & Heerdink, E. R. (2007). Aggression of psychiatric patients associated with the use of as-needed medication. Pharmacopsychiatry, 40(1), 25–29. https://doi.org/10.1055/s-2007-961817
   PubMed Web of Science ®Google Scholar
• Hales, H., & Gudjonsson, G. H. (2004). Effect of ethnic differences on the use of prn (as required) medication on an inner London medium secure unit. Journal of Forensic Psychiatry & Psychology, 15(2), 303–313.
   Web of Science ®Google Scholar
• Haw, C., & Wolstencroft, L. (2014). A study of the prescription and administration of sedative PRN medication to older adults at a secure hospital. International Psychogeriatrics, 26(6), 943–951. https://doi.org/10.1017/S1041610214000179
   PubMed Web of Science ®Google Scholar
• Hipp, K., Kuosmanen, L., Repo‐Tiihonen, E., Leinonen, M., Louheranta, O., & Kangasniemi, M. (2018). Patient participation in pro re nata medication in psychiatric inpatient settings: An integrative review. International Journal of Mental Health Nursing, 27(2), 536–554. https://doi.org/10.1111/inm.12427
   PubMed Web of Science ®Google Scholar
• Jimu, M., & Doyle, L. (2019). The administration of pro re nata medication by mental health nurses: A thematic analysis. Issues in Mental Health Nursing, 40(6), 511–517. https://doi.org/10.1080/01612840.2018.1543739
   PubMed Web of Science ®Google Scholar
• Kaunomäki, J., Jokela, M., Kontio, R., Laiho, T., Sailas, E., & Lindberg, N. (2017). Interventions following a high violence risk assessment score: A naturalistic study on a Finnish psychiatric admission ward. BMC Health Services Research, 17(1), 26. https://doi.org/10.1186/s12913-016-1942-0
   PubMed Web of Science ®Google Scholar
• Keinänen, J. (2018). Metabolic changes, inflammation and mortality in psychotic disorders [Doctoral dissertation]. Helsingin yliopisto. Retrieved from http://urn.fi/URN:ISBN:978-951-51-4567-3
   Google Scholar
• Kuivalainen, S., Vehviläinen-Julkunen, K., Louheranta, O., Putkonen, A., Repo-Tiihonen, E., & Tiihonen, J. (2017). De-escalation techniques used, and reasons for seclusion and restraint, in a forensic psychiatric hospital. International Journal of Mental Health Nursing, 26(5), 513–524. https://doi.org/10.1111/inm.12389
   PubMed Web of Science ®Google Scholar
• Kumpula, E., Gustafsson, L., & Ekstrand, P. (2019). Nursing staff talk. Journal of Forensic Nursing, 15(1), 52–59. https://doi.org/10.1097/JFN.0000000000000227
   PubMed Web of Science ®Google Scholar
• Lee, A. H., & DiGiuseppe, R. (2018). Anger and aggression treatments: A review of meta-analyses. Current Opinion in Psychology, 19, 65–74. https://doi.org/10.1016/j.copsyc.2017.04.004
   PubMed Web of Science ®Google Scholar
• Maguire, T., Daffern, M., Bowe, S. J., & McKenna, B. (2018). Risk assessment and subsequent nursing interventions in a forensic mental health inpatient setting: Associations and impact on aggressive behaviour. Journal of Clinical Nursing, 27(5–6), e971–e983. https://doi.org/10.1111/jocn.14107
   PubMed Web of Science ®Google Scholar
• Martin, K., Arora, V., Fischler, I., & Tremblay, R. (2017). Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital. International Journal of Mental Health Nursing, 26(4), 402–408. https://doi.org/10.1111/inm.12265
   PubMed Web of Science ®Google Scholar
• Mental Health Act. (1990). Mental Health Act, 1116/1990. Retrieved from https://www.finlex.fi/fi/laki/kaannokset/1990/en19901116_20101338.pdf
   Google Scholar
• Molloy, L., Field, J., Beckett, P., & Holmes, D. (2012). PRN psychotropic medication and acute mental health nursing: Reviewing the evidence. Journal of Psychosocial Nursing and Mental Health Services, 50(8), 12–15. https://doi.org/10.3928/02793695-20120703-03
   PubMed Web of Science ®Google Scholar
• Monrad Aas, I. H., Sonesson, O., & Torp, S. (2018). A qualitative study of clinicians experience with rating of the Global Assessment of Functioning (GAF) scale. Community Mental Health Journal, 54(1), 107–1116. https://doi.org/10.1007/s10597-016-0067-6
   PubMed Web of Science ®Google Scholar
• Nedopil, N., Taylor, P., & Gunn, J. (2015). Forensic psychiatry in Europe: The perspective of the Ghent Group. International Journal of Psychiatry in Clinical Practice, 19(2), 80–83. https://doi.org/10.3109/13651501.2014.967700
   PubMed Web of Science ®Google Scholar
• Nicholls, T. L., Brink, J., Greaves, C., Lussier, P., & Verdun-Jones, S. (2009). Forensic psychiatric inpatients and aggression. An exploration of incidence, prevalence, severity, and interventions by gender. International Journal of Law and Psychiatry, 32(1), 23–30. https://doi.org/10.1016/j.ijlp.2008.11.007
   PubMed Web of Science ®Google Scholar
• Patel, J., Frankel, S., & Tampi, R. R. (2019). Evidence of using PRN pharmacotherapy to treat undifferentiated acute agitation and aggression. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists, 31(1), 54–69.
   PubMed Web of Science ®Google Scholar
• Putkonen, A., Kuivalainen, S., Louheranta, O., Repo-Tiihonen, E., Ryynänen, O. P., Kautiainen, H., & Tiihonen, J. (2013). Cluster-randomized controlled trial of reducing seclusion and restraint in secured care of men with schizophrenia. Psychiatric Services, 64(9), 850–855. https://doi.org/10.1176/appi.ps.201200393
   PubMed Web of Science ®Google Scholar
• Rief, W., & Martin, A. (2014). How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: A critical evaluation and a proposal for modifications. Annual Review of Clinical Psychology, 10(1), 339–367. https://doi.org/10.1146/annurev-clinpsy-032813-153745
   PubMedGoogle Scholar
• Stewart, D., Robson, D., Chaplin, R., Quirk, A., & Bowers, L. (2012). Behavioural antecedents to pro re nata psychotropic medication administration on acute psychiatric wards. International Journal of Mental Health Nursing, 21(6), 540–549. https://doi.org/10.1111/j.1447-0349.2012.00834.x
   PubMed Web of Science ®Google Scholar
• The National Institute for Health and Care Excellence (NICE). (2015). Violence and aggression: short-term management in mental health, health and community settings (NICE guideline 10). Retrieved from nice.org.uk/guidance/ng10
   Google Scholar
• Usher, K., Baker, J. A., Holmes, C., & Stocks, B. (2009). Clinical decision-making for ‘as needed’ medications in mental health care. Journal of Advanced Nursing, 65(5), 981–991. https://doi.org/10.1111/j.1365-2648.2008.04957.x
   PubMed Web of Science ®Google Scholar
• Vaismoradi, M., Amaniyan, S., & Jordan, S. (2018). Patient safety and pro re nata prescription and administration: A systematic review. Pharmacy, 6(3), 95. https://doi.org/10.3390/pharmacy6030095
   Web of Science ®Google Scholar
• Wright, S., Stewart, D., & Bowers, L. (2012). Psychotropic PRN medication in inpatient psychiatric care: A literature review. Report from the Conflict and Containment Reduction Research Programme. Institute of Psychiatry at the Maudsley. Retrieved from https://www.kcl.ac.uk/ioppn/depts/hspr/archive/mhn/projects/PRN-Medication-Review.pdf
   Google Scholar
• Zaman, H., Sampson, S., Beck, A., Sharma, T., Clay, F., Spyridi, S., Zhao, S., & Gillies, D. (2018). Benzodiazepines for psychosis-induced aggression or agitation. Schizophrenia Bulletin, 44(5), 966–969. https://doi.org/10.1093/schbul/sby056
   PubMed Web of Science ®Google Scholar